11
Views
16
CrossRef citations to date
0
Altmetric
Original articles

Effects of Prazosin and Carbachol in Patients with Benign Prostatic Obstruction

&
Pages 19-22 | Published online: 31 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

H. Nordgren, S. Nilsson, S. Eklöv, P. Stattin, W. Naining, T. Heiden, L. Bergkvist, L. Karlberg, C. Lundholm, B. Harvig, P. Strang, R. Bergström & B. Tribukait. (1991) Modal DNA Values and Estramustine-Binding Protein (EMBP) as Prognostic Markers in Prostatic Cancer. Acta Oncologica 30:2, pages 211-214.
Read now
Mirja L. Ruutu, Erkki Hansson, Harri E. Juusela, Jaakko E. Permi, Jan I. Rusk, Martti T. Sotarauta, Martti T. Talja, Eero J. Wuokko & Mauri J. Mattila. (1991) Efficacy and Side-Effects of Prazosin as a Symptomatic Treatment of Benign Prostatic Obstruction. Scandinavian Journal of Urology and Nephrology 25:1, pages 15-19.
Read now

Articles from other publishers (14)

K. Höfner, T. Bach, R. Berges, K. Dreikorn, C. Gratzke, S. Madersbacher, M.-S. Michel, R. Muschter, M. Oelke, O. Reich, C. Tschuschke & T. Bschleipfer. (2015) S2e-Leitlinie der Deutschen UrologenS2e guideline of the German urologists. Der Urologe 55:2, pages 184-194.
Crossref
K.-E. Andersson. 2011. Urinary Tract. Urinary Tract 319 344 .
Barbara B.M Kortmann, Diamandis L Floratos, Lambertus A.L.M Kiemeney, Hessel Wijkstra & Jean J.M.C.H de la Rosette. (2003) Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials. Urology 62:1, pages 1-9.
Crossref
Sharmaine Ramasamy, Wayne C Hodgson & Sabatino Ventura. (2002) Protein kinase C and the sub-sensitivity and sub-reactivity of the diabetic rat prostate gland to noradrenaline. European Journal of Pharmacology 434:3, pages 151-161.
Crossref
Gabe S. Sonke, Barbara B.M. Kortmann, Andr� L.M. Verbeek, Lambertus A.L.M. Kiemeney, Frans M.J. Debruyne & Jean J.M.C.H. de la Rosette. (2000) Variability of pressure-flow studies in men with lower urinary tract symptoms. Neurourology and Urodynamics 19:6, pages 637-656.
Crossref
J.L.H. Ruud Bosch. (1997) URODYNAMIC EFFECTS OF VARIOUS TREATMENT MODALITIES FOR BENIGN PROSTATIC HYPERPLASIA. Journal of Urology 158:6, pages 2034-2044.
Crossref
Lars M. Eri & Kjell J. Tveter. (1995) Alpha-Blockade in the Treatment of Symptomatic Benign Prostatic Hyperplasia. Journal of Urology 154:3, pages 923-934.
Crossref
C.R. CHAPPLE, P. CARTER, T.J. CHRISTMAS, R. S. KIRBY, J. BRYAN, E. J. G. MILROY & P. ABRAMS. (2008) A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction. British Journal of Urology 74:1, pages 50-56.
Crossref
Christopher R. ChappleC. R. Chapple & I. R. Marshall. 1994. Prostatic Obstruction. Prostatic Obstruction 189 212 .
C. R. CHAPPLE, M. STOTT, P. H. ABRAMS, T. J. CHRISTMAS & E. J. G. MILROY. (2008) A 12‐Week Placebo‐controlled Double‐blind Study of Prazosin in the Treatment of Prostatic Obstruction due to Benign Prostatic Hyperplasia. British Journal of Urology 70:3, pages 285-294.
Crossref
C. R. Chapple. 1992. Benign Prostatic Hyperplasia. Benign Prostatic Hyperplasia 155 171 .
O. Lukkarinen. (1991) Effect of LH-RH analogue in patients withbenign prostatic hyperplasia. Urology 37:2, pages 92-94.
Crossref
Marco Caine. (1990) Alpha-Adrenergic Blockers for the Treatment of Benign Prostatic Hyperplasia. Urologic Clinics of North America 17:3, pages 641-649.
Crossref
K.-E. Andersson & H. Hedlund. 1990. Cholinergic Neurotransmission: Functional and Clinical Aspects. Cholinergic Neurotransmission: Functional and Clinical Aspects 201 207 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.